Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$15.75 - $21.38 $8,127 - $11,032
-516 Reduced 2.86%
17,556 $368,000
Q3 2023

Nov 07, 2023

SELL
$20.22 - $27.36 $58,233 - $78,796
-2,880 Reduced 13.75%
18,072 $383,000
Q2 2023

Aug 04, 2023

SELL
$19.39 - $28.9 $65,673 - $97,884
-3,387 Reduced 13.92%
20,952 $565,000
Q1 2023

May 08, 2023

SELL
$12.71 - $21.17 $9,672 - $16,110
-761 Reduced 3.03%
24,339 $478,000
Q4 2022

Feb 10, 2023

BUY
$11.23 - $19.44 $31,780 - $55,015
2,830 Added 12.71%
25,100 $341,000
Q3 2022

Nov 10, 2022

BUY
$12.2 - $18.71 $19,959 - $30,609
1,636 Added 7.93%
22,270 $389,000
Q2 2022

Aug 12, 2022

BUY
$12.05 - $22.74 $248,639 - $469,217
20,634 New
20,634 $272,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $455M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.